What Is Opko Health, Inc. (OPK) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Opko Health, Inc.'s intrinsic value is estimated at $0.69. Trading at its current price of $1.20, the valuation engine raises significant caution: 9 of 12 models flag downside risk, projecting an average implied return of -42.8%. The most optimistic model, PWERM, places fair value at $1.57 (+31.0%), while Sentiment SOTP — the most conservative — estimates $0.09 (-92.2%). This +123.2% gap reflects genuine analytical uncertainty about Opko Health, Inc.'s intrinsic worth.
What Do the Models Say About OPK?
12 of 13 models are currently active for OPK. Of these, 1 model suggests upside while 11 models suggest overvaluation. The Bayesian DCF estimates OPK's intrinsic value at $0.31, implying -73.8% downside from the current price. See which stocks rank higher →
How Does OPK Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, OPK ranks #122 by Quality of Company score. CirclFi's QOC score of 6.1/10 evaluates 32 fundamental signals. A score of 6.1 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Opko Health, Inc.'s positioning within the Pharmaceutical Preparations segment means that FDA approval probability plays an outsized role in fundamental analysis. The sector's unique characteristics — including regulatory pathway clarity — shape both the opportunity set and risk profile.
Is OPK a Value Trap?
CirclFi's Value Trap algorithm assigns OPK a score of 32/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Opko Health, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Opko Health, Inc. scores 6.1 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +123.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every OPK valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across OPK's 12 active models, average confidence is 34%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad